Report Detail
Global Ivosidenib Drugs Market Insights, Forecast to 2025
- RnM3447658 |
- 22 May, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Ivosidenib is an experimental drug for treatment of cancer. It is a small molecule inhibitor of IDH1, which is mutated in several forms of cancer.
The global Ivosidenib Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Ivosidenib Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Ivosidenib Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Ivosidenib Drugs in these regions.
This research report categorizes the global Ivosidenib Drugs market by top players/brands, region, type and end user. This report also studies the global Ivosidenib Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Agios Pharmaceuticals
Market size by Product
60 Tablets
30 Tablets
Market size by End User
Hospital
Pharmacy
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Ivosidenib Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Ivosidenib Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Ivosidenib Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Ivosidenib Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Ivosidenib Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Ivosidenib Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Ivosidenib Drugs Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Ivosidenib Drugs Market Size Growth Rate by Product
- 1.4.2 60 Tablets
- 1.4.3 30 Tablets
- 1.5 Market by End User
- 1.5.1 Global Ivosidenib Drugs Market Size Growth Rate by End User
- 1.5.2 Hospital
- 1.5.3 Pharmacy
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Ivosidenib Drugs Market Size
- 2.1.1 Global Ivosidenib Drugs Revenue 2014-2025
- 2.1.2 Global Ivosidenib Drugs Sales 2014-2025
- 2.2 Ivosidenib Drugs Growth Rate by Regions
- 2.2.1 Global Ivosidenib Drugs Sales by Regions
- 2.2.2 Global Ivosidenib Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Ivosidenib Drugs Sales by Manufacturers
- 3.1.1 Ivosidenib Drugs Sales by Manufacturers
- 3.1.2 Ivosidenib Drugs Sales Market Share by Manufacturers
- 3.1.3 Global Ivosidenib Drugs Market Concentration Ratio (CR5 and HHI)
- 3.2 Ivosidenib Drugs Revenue by Manufacturers
- 3.2.1 Ivosidenib Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Ivosidenib Drugs Revenue Share by Manufacturers (2014-2019)
- 3.3 Ivosidenib Drugs Price by Manufacturers
- 3.4 Ivosidenib Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Ivosidenib Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Ivosidenib Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Ivosidenib Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Ivosidenib Drugs Sales by Product
- 4.2 Global Ivosidenib Drugs Revenue by Product
- 4.3 Ivosidenib Drugs Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Ivosidenib Drugs Breakdown Data by End User
6 North America
- 6.1 North America Ivosidenib Drugs by Countries
- 6.1.1 North America Ivosidenib Drugs Sales by Countries
- 6.1.2 North America Ivosidenib Drugs Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Ivosidenib Drugs by Product
- 6.3 North America Ivosidenib Drugs by End User
7 Europe
- 7.1 Europe Ivosidenib Drugs by Countries
- 7.1.1 Europe Ivosidenib Drugs Sales by Countries
- 7.1.2 Europe Ivosidenib Drugs Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Ivosidenib Drugs by Product
- 7.3 Europe Ivosidenib Drugs by End User
8 Asia Pacific
- 8.1 Asia Pacific Ivosidenib Drugs by Countries
- 8.1.1 Asia Pacific Ivosidenib Drugs Sales by Countries
- 8.1.2 Asia Pacific Ivosidenib Drugs Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Ivosidenib Drugs by Product
- 8.3 Asia Pacific Ivosidenib Drugs by End User
9 Central & South America
- 9.1 Central & South America Ivosidenib Drugs by Countries
- 9.1.1 Central & South America Ivosidenib Drugs Sales by Countries
- 9.1.2 Central & South America Ivosidenib Drugs Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Ivosidenib Drugs by Product
- 9.3 Central & South America Ivosidenib Drugs by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Ivosidenib Drugs by Countries
- 10.1.1 Middle East and Africa Ivosidenib Drugs Sales by Countries
- 10.1.2 Middle East and Africa Ivosidenib Drugs Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Ivosidenib Drugs by Product
- 10.3 Middle East and Africa Ivosidenib Drugs by End User
11 Company Profiles
- 11.1 Agios Pharmaceuticals
- 11.1.1 Agios Pharmaceuticals Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Agios Pharmaceuticals Ivosidenib Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Agios Pharmaceuticals Ivosidenib Drugs Products Offered
- 11.1.5 Agios Pharmaceuticals Recent Development
12 Future Forecast
- 12.1 Ivosidenib Drugs Market Forecast by Regions
- 12.1.1 Global Ivosidenib Drugs Sales Forecast by Regions 2019-2025
- 12.1.2 Global Ivosidenib Drugs Revenue Forecast by Regions 2019-2025
- 12.2 Ivosidenib Drugs Market Forecast by Product
- 12.2.1 Global Ivosidenib Drugs Sales Forecast by Product 2019-2025
- 12.2.2 Global Ivosidenib Drugs Revenue Forecast by Product 2019-2025
- 12.3 Ivosidenib Drugs Market Forecast by End User
- 12.4 North America Ivosidenib Drugs Forecast
- 12.5 Europe Ivosidenib Drugs Forecast
- 12.6 Asia Pacific Ivosidenib Drugs Forecast
- 12.7 Central & South America Ivosidenib Drugs Forecast
- 12.8 Middle East and Africa Ivosidenib Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Ivosidenib Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Ivosidenib Drugs . Industry analysis & Market Report on Ivosidenib Drugs is a syndicated market report, published as Global Ivosidenib Drugs Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Ivosidenib Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
